Biotech componentsAnimal

Products 21 to 30 of 38

Houseplant with Rabbit DNA by University of Washington
Biotech components: Animal + Plant
Business models: N/A
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/04/01 10:01 (4 years ago)
Date last modified: 2019/04/01 10:01 (4 years ago)
Known funding amount: N/A
Funding types: University
Industry: N/A
Market status: Under Development
Organization type(s): University
Product categories: Plant
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Humanized Pig Organs by Synthetic Genomics + United Therapeutics’ Lung Biotechnology Inc
Biotech components: Animal
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Research
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/09/28 15:05 (4 years ago)
Known funding amount: 40,000,000 USD
Funding types: Venture Capital
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Animal + Molecule
Business models: N/A
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/04/01 10:01 (4 years ago)
Date last modified: 2019/04/12 09:36 (4 years ago)
Known funding amount: N/A
Funding types: N/A
Industry: Medical
Market status: Under Development + More information needed
Organization type(s): N/A
Product categories: N/A
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Integriculture Cellular Meat by Integriculture Inc.
Biotech components: Animal
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/07/02 11:19 (4 years ago)
Date last modified: 2019/07/02 11:19 (4 years ago)
Known funding amount: 300,000,000
Funding types: Venture Capital
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Food
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Mast-MO (antibiotic wasp venom) by University of Pennsylvania’s Perelman School of Medicine
Biotech components: Animal + Bacteria + Molecule
Business models: B2B + B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:40 (2 years ago)
Date last modified: 2020/12/18 14:40 (2 years ago)
Known funding amount: N/A
Funding types: University
Industry: Medical
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Medusoid: Tissue-Engineered Biomimetic Jellyfish by Harvard University + Caltech
Biotech components: Animal
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Research + Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: N/A
Funding types: University
Industry: Health
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medical (Device)
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Monster Silk by Kraig Biocraft Laboratories
Biotech components: Animal
Business models: B2B
Country of production: USA
Country of distribution: USA + Vietnam
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: 5,000,000 USD
Funding types: Government + Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Fiber
Production process: Closed Production
Source: Web search
Trading symbol: KBLB (OTCMKTS)
Value chain stage: Input
Mosameat by Mosameat
Biotech components: Animal
Business models: B2B + B2C
Country of production: Netherlands
Country of distribution: Netherlands
Intended consumer: Commercial + Consumer
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/10/08 14:50 (4 years ago)
Known funding amount: 7,500,000 EUR
Funding types: Private Funding
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Food
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Animal
Business models: B2B
Country of production: USA
Country of distribution: USA + Canada
Intended consumer: Commercial + Government + TBD
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: 295,172 USD
Funding types: Government + Venture Capital
Industry: Food & Agriculture + Health
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Soil Amendment + Medical Treatment + Other (Industrial)
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Biotech components: Animal + Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:53 (3 years ago)
Date last modified: 2019/09/12 14:53 (3 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture + Industrial
Market status: Under Development
Organization type(s): Public Company
Product categories: Animal + Food
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product